CHM 0.00% 0.9¢ chimeric therapeutics limited

cranswick--mim v savage resources

  1. 80 Posts.
    Cranwick,
    You continually refer to MMX as a ASX200 company and would all these instutional investors not have done their homework first.

    Just look up MIM v Savage and their Ernst Henry Asset.

    The management of MMX know the previous management may have cut corners, but have been in denial on the impact their action may have on the current workings/assets of MMX.It is now coming home to roost.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.